| Ticker | HZNP |
|---|---|
| ISIN | IE00BQPVQZ61 |
| Sector | Atención sanitaria |
| Mercado | NASDAQ |
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines in the areas of rare diseases, gout, ophthalmology, and inflammation. It markets TEPEZZA (teprotumumab-trbw) for intravenous infusion; KRYSTEXXA (pegl...
Horizon Pharma opera en el sector Healthcare, industria Drug Manufacturers - General.